Stockreport

Virpax’s NES100 to be Presented at The Society of Toxicology by NCATS

VIRPAX PHARMS INC  (VRPX) 
PDF BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products fo [Read more]